Skip to Main Content
Directory of Faculty Research Interests
YSM Home

INFORMATION FOR

Adam de Havenon, MD, MS

DownloadHi-Res Photo

Research

About

Titles

Associate Professor Term

Biography

Dr. de Havenon is an Associate Professor of Neurology. After receiving his B.A. from Yale University in 2001, he received his medical degree from Brown School of Medicine in 2009 and completed internship and neurology residency at the University of Utah in 2013. He finished a vascular neurology fellowship at University of Washington in 2014 and was a faculty member at the University of Utah from 2014-2021. In late 2021, Dr. de Havenon returned to Yale. His clinical practice includes evaluating and treating patients with acute neurologic disease in the hospital and emergency department. He has a particular clinical interest in stroke, cognitive impairment, and common neurological emergencies such as seizure or encephalitis. Dr. de Havenon has published over 200 peer-reviewed articles and his research into stroke, cognitive impairment, and advanced neuroimaging has received funding from the National Institutes of Health, American Academy of Neurology, and American Heart Association.

Last Updated on March 21, 2026.

Appointments

  • Neurology

    Associate Professor on Term
    Primary
    Neurology

Other Departments & Organizations

Education & Training

MS
University of Utah (2021)
Vascular Neurology Fellow
University of Washington (2014)
Neurology Resident
University of Utah (2013)
MD
Brown Medical School (2009)
BA
Yale University, American Studies (2001)

Research

Overview

During my neurology training, I discovered that I want the expertise to successfully fill the space between the basic science of stroke and dementia research and its implementation in human subjects. My long-term research goal is to bridge these fields and lead a team of basic and clinical researchers to address the most treatment-resistant diseases in neurology and to provide excellent care to patients suffering from these diseases. I have consistently obtained competitive grant awards, including a K23, R01, R21, and UG3/UH3 from NIH/NINDS. In 2021, I finished a Masters of Science in Clinical Investigation degree. I am the principal investigator of the observational trial in my K23, the multicenter BP-VISO study, and the StrokeNet studies CAPTIVA-MRI and Clarity. At my prior institution, I established the de Havenon Lab and mentees in my lab received a number of research awards and scholarships. In 2022, we established the de Havenon lab at Yale and have been expanding its footprint. The lab's goal is to advance research that will benefit patients with stroke and to help train the next generation of stroke and cognitive impairment researchers.

Research at a Glance

Yale Co-Authors

Frequent collaborators of Adam de Havenon's published research.

Publications

2026

See All Publications

Clinical Trials

Current Trials

Clinical Care

Overview

Adam de Havenon, MD, is a neurohospitalist and vascular neurologist who cares for patients with a broad range of acute neurologic diseases in the hospital and emergency department. His clinical practice includes evaluating and treating patients with stroke, seizure, encephalitis, intracranial hemorrhage, vascular malformations, aneurysms, and other neurologic emergencies. He has particular clinical interests in acute neurologic care, vascular cognitive impairment, and cerebrovascular disease.

“I was always interested in the brain, and I knew in medical school that I wanted to be a neurologist,” Dr. de Havenon says. “During residency, I was drawn to hospital-based neurology because neurologic emergencies are often complex, fast-moving, and highly meaningful for patients and families. Rapid diagnosis and treatment can make an enormous difference in recovery and long-term outcomes.”

Dr. de Havenon says one of the most rewarding aspects of neurohospitalist care is the breadth of neurologic disease encountered in the hospital setting. “Every day is different,” he says. “You may be caring for a patient with stroke, status epilepticus, encephalitis, severe headache, or another acute neurologic condition. Advances in neuroimaging, monitoring, and acute treatments have dramatically improved our ability to diagnose and treat these diseases quickly and effectively.”


He emphasizes the importance of seeking immediate medical attention for sudden neurologic symptoms, including weakness, difficulty speaking, confusion, seizure, severe headache, vision changes, or difficulty walking. Dr. de Havenon’s clinical work and research are closely connected. His research focuses on vascular cognitive impairment, stroke prevention, intracranial atherosclerosis, and advanced neuroimaging. “My goal is to improve both acute neurologic care and long-term brain health,” he says. “Whether treating a neurologic emergency in the hospital or studying ways to prevent cognitive decline and future neurologic injury, the focus is always on improving patients’ quality of life.”

Clinical Specialties

Neurology

Fact Sheets

See All Fact Sheets On Yale Medicine

Yale Medicine News

See All News On Yale Medicine

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Get In Touch

Contacts

Email
Appointment Number
Mobile Phone Number
Mailing Address

Neurology

15 York St

New Haven, CT 06510

United States

Administrative Support

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    See Patient Care Locations